Age
|
59 (34, 72)
|
64(22, 85)
|
0.138
|
Gender(Male/Female)
|
9/2
|
26/9
|
1.000
|
Involved region
| | | |
Upper extremity
|
5 (45.5)
|
10 (28.6)
|
0.462
|
Lower extremity
|
6 (54.5)
|
25 (71.4)
| |
TiOA(day)
|
7.18 (2, 14)
|
2.43 (0.5, 14)*
|
< 0.001
|
TiOS(hour)
|
25.64 (2, 72)
|
11.74 (1, 72)*
|
0.046
|
Immunocompromised(DM, liver dysfunction, Chronic renal failure, Malignancy)
|
5 (45.5)
|
29 (82.8)*
|
0.022
|
Comorbidity
| | | |
DM
|
5 (45.5)
|
13 (37.1)
|
0.728
|
Gout
|
5 (45.5)
|
2 (5.7)*
|
0.005
|
Chronic renal failure (> 1.6 mg/dL)
|
2 (18.2)
|
7 (20)
|
1.000
|
Chronic Liver dysfunction
|
1 (9.1)
|
18 (51.4)*
|
0.016
|
HBV
|
0 (0)
|
11 (31.4)*
|
0.044
|
HCV
|
1 (9.1)
|
11 (31.4)
|
0.241
|
HBV or HCV
|
1 (9.1)
|
17 (48.6)*
|
0.032
|
Liver cirrhosis
|
0
|
8 (22.9)
|
0.619
|
ICU stay(patient number)
|
4 (36.4)
|
26 (74.3)*
|
0.032
|
Post-operative mechanical ventilation (patient number)
|
4 (36.4)
|
24 (68.6)
|
0.080
|
APACHE II score
|
12.9 (3, 21)
|
18.9 (2, 34)*
|
0.015
|
ICU stay (day)
|
2 (0, 7)
|
4.3 (0, 16)
|
0.077
|
Hospital stay (day)
|
35.7 (15, 70)
|
35.8 (13, 87)
|
0.800
|
Amputation
|
0
|
5 (10.9)
|
0.317
|
STSG
|
5 (45.5)
|
21 (60)
|
0.494
|
Free flap transfer
|
1 (9.1)
|
7 (20)
|
0.658
|
Mortality
|
1(9.1)
|
6(17.1)
|
1.000
|